Alto Ingredients, Inc. (ALTO) Market Cap & Valuation Ratios
Alto Ingredients, Inc. (ALTO) has a market cap of $280.0M, a trailing P/E of 5.3 and a price-to-sales ratio of 0.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALTOAlto Ingredients, Inc.Follow ALTO — free
—
Price chart with a free account
- Market cap
- 280.0M
- P/E TTM
- 5.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Peers
chemicals · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| ALTO | 0.3 | 5.3 | 0.3 | 5.2 | 17.8% | +1% | 4% | 9% |
| REX | 1.3 | 10.9 | 1.4 | 5.2 | 5.2% | +1% | 25% | 29% |
| GPRE | 1.0 | 9.1 | 0.7 | 5.5 | 13.0% | -24% | 7% | 9% |
| KRO | 0.9 | — | 0.7 | 47.2 | -4.5% | +3% | -2% | -2% |
| LXU | 0.7 | 19.8 | 1.4 | 6.4 | 12.1% | +22% | 10% | 6% |
| TROX | 0.6 | — | 1.2 | 40.3 | — | +4% | -7% | -5% |
| RYAM | 0.5 | — | 0.8 | 13.6 | -8.1% | -3% | -3% | -5% |
| ASIX | 0.4 | — | 0.4 | 9.6 | -6.1% | +3% | -0.7% | -1.0% |
| VHI | 0.4 | — | 0.4 | 5.3 | 15.5% | +3% | 4% | 4% |
| NL | 0.3 | — | 1.4 | 12.0 | 2.5% | +6% | 9% | 5% |
| ASPI | 0.3 | — | 9.9 | — | — | +573% | -321% | -32% |
| Median of these 10 | 10.9 | 1.0 | 9.6 | 3.8% | +3% | 1% | 2% |
P/E 5.3 vs. a peer median of 10.9; EV/Sales 0.3 vs. 1.0.
Growth vs. price
each dot a company · hover or tap for valuesKRO and TROX and RYAM and ASIX and VHI and NL and ASPI have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Alto Ingredients, Inc. — questions
- What is Alto Ingredients, Inc.'s market cap?
- $280.0M.
- What is Alto Ingredients, Inc.'s P/E ratio?
- 5.3 on trailing twelve-month earnings to 2026-06-30.
- What is Alto Ingredients, Inc.'s price-to-sales ratio?
- 0.3.
Every figure on this page comes from Alto Ingredients, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.